Drug Database
Back to search

Japan· JP-3999007F1031

イノシンプラノベクス

A inosine pranobex product containing イノシンプラノベクス, registered in Japan by 持田製薬, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.

On Japan’s NHI price listATC J05AX05

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedイノシンプラノベクスATCJ05AX05REGISTER NO.JP-3999007F1031PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about イノシンプラノベクスAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Inosine pranobex is registered in 7 of 19 countries.

Countries holding a registration under ATC J05AX05 (inosine pranobex), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 4 of them publish a price we can compare per daily dose
Search inosine pranobex products by name

Inosine pranobex · ATC J05AX05

7 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
イノシンプラノベクス
Manufacturer
持田製薬
Country
Japan (JP)
ATC code
J05AX05
ATC class
Inosine pranobex
Defined daily dose
3 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Inosine pranobex in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All inosine pranobex products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Bulgaria · Pranosine Forte, Аквир С Вкус На Ягода
  • Czechia · Isoprinosine
  • United Kingdom (Northern Ireland) · Imunovir
  • Hungary · Inosine Pranobex Q Pharma Kft., Isoprinosine
  • Ireland · Imunovir
  • Lithuania · Isoprinosine
  • Latvia · Isoprinosine
  • Poland · Akvir, Akvir Forte O Smaku Truskawkowym
  • Romania · Groprinosin, Inovira
  • Slovakia · Inomed, Isoprinosine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8062daf4-3d11-4bd8-9de5-9917b374192f
GET /v1/drugs/8062daf4-3d11-4bd8-9de5-9917b374192f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "４００ｍｇ１錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3999007F1031",
  "category": "内用薬",
  "price_yen": 133.9,
  "generic_name": "イノシンプラノベクス",
  "product_name_jp": null,
  "therapeutic_class": "3999",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about inosine pranobex.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console